Table 1.
Baseline Clinical and Laboratory Characteristics of the Subjects
| Characteristic | Value |
|---|---|
| Number | 194 |
| Sex, male/female | 137/57 |
| Age, yr | 57.6±9.0 |
| Smoking | 70 (35.9) |
| Height, cm | 162.0±14.3 |
| Body weight, kg | 69.9±11.6 |
| BMI, kg/m2 | 26.0±3.1 |
| WC, cm | 89.7±8.3 |
| Systolic BP, mm Hg | 138.3±17.0 |
| Diastolic BP, mm Hg | 82.2±10.0 |
| Duration of DM, yr | 7.6±6.7 |
| C-peptide, ng/mL | 2.2±0.9 |
| HbA1c, % | 7.0±0.9 |
| Creatinine, mg/dL | 1.0±0.2 |
| hsCRP, mg/dL | 0.17±0.4 |
| ALT, IU/L | 31.7±19.4 |
| AST, IU/L | 26.67 ±12.2 |
| TC, mg/dL | 169.5±34.1 |
| TG, mg/dL | 128.7±80.3 |
| HDL-C, mg/dL | 48.0±11.7 |
| LDL-C, mg/dL | 102.4±30.9 |
| Use of sulfonylurea | 159 (81.5) |
| Use of metformin | 112 (57.4) |
| Use of thiazolinedione | 16 (8.2) |
| Use of DPP4i | 22 (11.3) |
Values are expressed as mean±standard deviation or number (%).
BMI, body mass index; WC, waist circumference; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; hsCRP, high sensitivity C-reactive protein; ALT, alanine transaminase; AST, aspartate transaminase; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; DPP4i, dipeptidyl peptidase-4 inhibitor.